Literature DB >> 3240734

Effects of long term oral administration of ketanserin and trichlormethiazide on blood pressure in stroke-prone spontaneously hypertensive rats.

M Minami1, N Hamaue, H Togashi, M Matsumoto, M Yoshioka, H Saito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3240734     DOI： 10.2165/00003495-198800361-00016

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  13 in total

1.  Comparative effects of prazosin and phenoxybenzamine on arterial blood pressure, heart rate, and plasma catecholamines in essential hypertension.

Authors:  J Mulvihill-Wilson; R M Graham; W Pettinger; C Muckleroy; S Anderson; F A Gaffney; C G Blomqvist
Journal:  J Cardiovasc Pharmacol       Date:  1979 Nov-Dec       Impact factor: 3.105

2.  Decreased monoamine oxidase activity in stroke-prone spontaneously hypertensive rat kidneys.

Authors:  M Senjo; N Yamazaki; M Minami; M Hirokami; H Saito; H Parvez
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1986-05

3.  Is ketanserin a D receptor antagonist?

Authors: 
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

4.  Causes of inadequate response to antihypertensive drugs. Volume factors.

Authors:  H P Dustan
Journal:  Hypertension       Date:  1983 Sep-Oct       Impact factor: 10.190

5.  Responses of the systemic circulation and of the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man.

Authors:  R Fagard; A Cattaert; P Lijnen; J Staessen; L Vanhees; E Moerman; A Amery
Journal:  Clin Sci (Lond)       Date:  1984-01       Impact factor: 6.124

6.  Ketanserin, a new selective 5-HT2 receptor blocking agent, inhibits the antidiuretic effect of 5-hydroxytryptamine (5-HT) in Wistar rats.

Authors:  F Cantalamessa; G de Caro; M Massi; L G Micossi
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-02

7.  [Effects of new antihypertensive agent, 2-[4-(n-butyryl)-homopiperazine-1-ul]-4-amino-6, 7-dimethoxy-quinazoline (E-643), on blood pressure, urinary sodium excretion and urinary norepinephrine excretion rate in stroke-prone, spontaneously hypertensive rats].

Authors:  M Minami; H Togashi; M Sano; M Yoshioka; I Saito; K Morii; M Tochihara; M Hirogami; A Nomura; H Saito
Journal:  Hokkaido Igaku Zasshi       Date:  1985-07

8.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

9.  Plasma norepinephrine concentration and plasma dopamine-beta-hydroxylase activity in patients with congestive heart failure.

Authors:  M Minami; H Yasuda; N Yamazaki; S Kojima; H Nishijima; N Matsumura; H Togashi; Y Koike; H Saito
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

10.  Central sympathoinhibitory action of ketanserin in rats.

Authors:  M Yoshioka; M Matsumoto; H Togashi; M Minami; H Saito
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.